Fundraising FoxNextRNA Therapeutics
Cambridge, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into NextRNA Therapeutics
Sign up to see every warm intro you have to NextRNA Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NextRNA Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CN
Carl NovinaNamed on SEC filing
EP
Elena ProkupetsNamed on SEC filing
BP
Barry PoliskyNamed on SEC filing
AA
Andrea ArmstrongNamed on SEC filing
DV
Dominique VerhelleNamed on SEC filing
CH
Christine HendersonNamed on SEC filing
SL
Susan LangerNamed on SEC filing
FM
Fred MermelsteinNamed on SEC filing
KA
Kenneth AndersonNamed on SEC filing
DD
Drew DennisonNamed on SEC filing
Board
AB
MA
Investors · 1
Cobro VenturesreportedMcleanvia Arthur Becker · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Funding
SEC filings, press & company announcements$23.4M disclosed across 1 of 2 rounds · 2022–2024
- Undisclosed amountSeedOct 2024Source ↗
▶$23.4MraisedJan 2022 · 34 investors · BiotechnologyRule 506(b)
▶$23.4MraisedJan 2022 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl NovinaDirector
- Elena ProkupetsDirector
- Barry PoliskyDirector
- Andrea ArmstrongDirector
- Arthur BeckerDirector
- Dominique VerhelleDirector
- Marc A. CohenExecutive Officer, Director
- Christine HendersonDirector
- Susan LangerDirector
- Fred MermelsteinDirector
- Kenneth AndersonDirector
- Drew DennisonDirector
- Malcolm SalterDirector
- Julia NovinaExecutive Officer
- Alain CohenDirector
- Offering amount
- $50M
- Amount sold
- $23.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through NextRNA Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are NextRNA Therapeutics's investors?
- NextRNA Therapeutics's investors include Cobro Ventures.
- How much funding has NextRNA Therapeutics raised?
- NextRNA Therapeutics has disclosed $23.4M raised across 1 of its 2 known rounds.
- Where is NextRNA Therapeutics headquartered?
- NextRNA Therapeutics is headquartered in Cambridge, US.